pentobarbital will lessen the level or result of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will minimize the extent or influence of ziprasidone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Not known.
Elderly or debilitated individuals may respond to barbiturates with marked depression, pleasure, and confusion; in a few clients, barbiturates regularly generate excitement as an alternative to depression
pentobarbital will lessen the extent or impact of sildenafil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Strong CYP3A4 inducers are anticipated to result in considerable decreases in sildenafil plasma levels
pentobarbital will minimize the extent or effect of fosaprepitant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will minimize the extent or effect of eltrombopag by influencing hepatic enzyme CYP2C9/ten metabolism. Use Warning/Watch.
pentobarbital will minimize the level or outcome of diazepam intranasal by impacting hepatic/intestinal enzyme CYP3A4 get more info metabolism. Use Warning/Keep track of. Potent or moderate CYP3A4 inducers may perhaps boost level of diazepam elimination; for that reason, efficacy of diazepam might be lowered.
pentobarbital will lessen the extent or outcome of tamoxifen by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital decreases levels of elvitegravir/cobicistat/emtricitabine/tenofovir DF by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. May possibly produce loss of virologic reaction and feasible resistance.
Keep track of Intently (1)pentobarbital will reduce the level or outcome of osilodrostat by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the level or outcome of bedaquiline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Stay away from coadministration of bedaquiline with robust CYP3A4 inducers as a result of possible for decreased therapeutic influence
Workout warning when administered to patients with acute or Serious suffering; could lead to paradoxical excitement or vital symptoms may be masked
pentobarbital will minimize the extent or impact of etonogestrel by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
We only use high-quality, credible resources to be sure content accuracy and integrity. It is possible to find out more about how we be certain our content material is correct and latest by reading our editorial policy.